IRIDEX CORP (IRIX) Stock Price & Overview

NASDAQ:IRIX • US4626841013

Current stock price

0.99 USD
-0.36 (-26.67%)
At close:
1.02 USD
+0.03 (+3.03%)
After Hours:

The current stock price of IRIX is 0.99 USD. Today IRIX is down by -26.67%. In the past month the price decreased by -29.29%. In the past year, price decreased by -0.91%.

IRIX Key Statistics

52-Week Range0.79 - 1.6481
Current IRIX stock price positioned within its 52-week range.
1-Month Range0.9505 - 1.45
Current IRIX stock price positioned within its 1-month range.
Market Cap
17.018M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.26
Dividend Yield
N/A

IRIX Stock Performance

Today
-26.67%
1 Week
-26.67%
1 Month
-29.29%
3 Months
-19.51%
Longer-term
6 Months -13.91%
1 Year -0.91%
2 Years -66.78%
3 Years -51.23%
5 Years -85.33%
10 Years -90.31%

IRIX Stock Chart

IRIDEX CORP / IRIX Daily stock chart

IRIX Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to IRIX. When comparing the yearly performance of all stocks, IRIX is a bad performer in the overall market: 74.65% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IRIX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IRIX. Both the profitability and financial health of IRIX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IRIX Earnings

On March 26, 2026 IRIX reported an EPS of -0.01 and a revenue of 14.72M. The company beat EPS expectations (50.98% surprise) and missed revenue expectations (-2.1% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateMar 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.01
Revenue Reported14.72M
EPS Surprise 50.98%
Revenue Surprise -2.10%

IRIX Forecast & Estimates

7 analysts have analysed IRIX and the average price target is 3.06 USD. This implies a price increase of 209.09% is expected in the next year compared to the current price of 0.99.

For the next year, analysts expect an EPS growth of 72.54% and a revenue growth 7.32% for IRIX


Analysts
Analysts82.86
Price Target3.06 (209.09%)
EPS Next Y72.54%
Revenue Next Year7.32%

IRIX Groups

Sector & Classification

Index Membership

IRIX Financial Highlights

Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS increased by 51.85% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-5.09M
Industry RankSector Rank
PM (TTM) N/A
ROA -17.94%
ROE -108.67%
Debt/Equity 0.79
Chartmill High Growth Momentum
EPS Q2Q%80%
Sales Q2Q%15.91%
EPS 1Y (TTM)51.85%
Revenue 1Y (TTM)N/A

IRIX Ownership

Ownership
Inst Owners17.89%
Shares17.19M
Float11.94M
Ins Owners5.47%
Short Float %0.38%
Short Ratio0.54

IRIX Latest News, Press Relases and Analysis

About IRIX

Company Profile

IRIX logo image IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Company Info

IPO: 1996-02-16

IRIDEX CORP

1212 Terra Bella Ave

Mountain View CALIFORNIA 94043 US

CEO: David I. Bruce

Employees: 93

IRIX Company Website

IRIX Investor Relations

Phone: 13026587581

IRIDEX CORP / IRIX FAQ

Can you describe the business of IRIDEX CORP?

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.


Can you provide the latest stock price for IRIDEX CORP?

The current stock price of IRIX is 0.99 USD. The price decreased by -26.67% in the last trading session.


Does IRIDEX CORP pay dividends?

IRIX does not pay a dividend.


What is the ChartMill rating of IRIDEX CORP stock?

IRIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is IRIDEX CORP (IRIX) stock traded?

IRIX stock is listed on the Nasdaq exchange.


Is IRIDEX CORP (IRIX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IRIX.


What is the market capitalization of IRIX stock?

IRIDEX CORP (IRIX) has a market capitalization of 17.02M USD. This makes IRIX a Nano Cap stock.